This page shows the latest Nanobiotix news and features for those working in and with pharma, biotech and healthcare.
French biotech Nanobiotix has received a second 14m tranche from a European Investment Bank (EIB) loan, triggered by meeting two development objectives. ... Nanobiotix has previously received 16m from the EIB and can draw on the final 10m by July 2020.
loan to fund innovative nanomedicine platform. France's nanomedicine specialist Nanobiotix has secured 40m from the European Investment Bank (EIB) to fund its research. ... Philippe Mauberna, chief financial officer of Nanobiotix, said: “This loan will
Meanwhile, Nanobiotix filed for approval of its radio-enhancer drug NBTXR3 for STS in Europe last week, while CytRx has an improved doxorubicin candidate called aldoxorubicin in late-stage testing.
More from news
Approximately 2 fully matching, plus 1 partially matching documents found.
Dr Obrocea (pictured right) joins Nanobiotix as head of US clinical development, bringing 20 years of clinical research leadership to the role. ... Meanwhile, Kurdi (pictured left) becomes director of investor relations at Nanobiotix, moving from the
More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.
No results were found
HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...